Live Breaking News & Updates on கில்பர்ட் வென்றது

Stay updated with breaking news from கில்பர்ட் வென்றது. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Redirecting to 93rd Vifor Pharma Group Annual General Meeting


Regulatory News:
At today’s 93rd Annual General Meeting of Vifor Pharma Ltd., shareholders approved all proposed resolutions put forward by the Board of Directors. In view of the ongoing COVID-19 pandemic and in accordance with Ordinance 3 on measures to combat the coronavirus issued by the Swiss Federal Council, on the basis of Art. 8 of the new COVID-19 Act, shareholders were not permitted to attend the event in person. Shareholders exercised their rights exclusively through the independent proxy and 61.6% of the share capital was represented.
Shareholder approvals
Shareholders approved the Annual Report and the Annual Financial Statements of Vifor Pharma Ltd., as well as the consolidated Financial Statements of Vifor Pharma Group for 2020 by a large majority. The maximum possible 2022 remuneration for the Board of Directors and Executive Committee was also approved, as well as the 2020 Remuneration Report in a consultative vote. In addition, shareholders discharge ....

Alexandre Lebeaut , Romeo Cerutti , Vifor Pharma , Jacques Theurillat , Gilbert Achermann , Kim Stratton , Michel Burnier , Gianni Zampieri , Swiss Stock Exchange , Financial Statements Of Vifor Pharma Ltd , Swiss Exchange , Remuneration Committee , Financial Statements Of Vifor Pharma Group , Swiss Federal Council , Vifor Pharma Group , Meeting Of Vifor Pharma Ltd , Fresenius Medical Care , Regulatory News , Annual General Meeting , Vifor Pharma Ltd , Annual Report , Annual Financial Statements , Financial Statements , Executive Committee , Chairman Jacques Theurillat , Sue Mahony ,

Vifor Pharma Ltd.: 93rd Vifor Pharma Group Annual General Meeting


Vifor Pharma Ltd.: 93rd Vifor Pharma Group Annual General Meeting
Election of Dr. Alexandre LeBeaut and Åsa Riisberg as Independent Directors
Dividend of CHF 2.00 approved
Regulatory News:
At today s 93
rd Annual General Meeting of Vifor Pharma Ltd., shareholders approved all proposed resolutions put forward by the Board of Directors. In view of the ongoing COVID-19 pandemic and in accordance with Ordinance 3 on measures to combat the coronavirus issued by the Swiss Federal Council, on the basis of Art. 8 of the new COVID-19 Act, shareholders were not permitted to attend the event in person. Shareholders exercised their rights exclusively through the independent proxy and 61.6% of the share capital was represented. ....

Alexandre Lebeaut , Romeo Cerutti , Vifor Pharma , Jacques Theurillat , Julien Vignot , Gilbert Achermann , Kim Stratton , Michel Burnier , Nathalie Ponnier , Gianni Zampieri , Swiss Stock Exchange , Global Head Corporate Communications , Financial Statements Of Vifor Pharma Ltd , Swiss Exchange , Remuneration Committee , Financial Statements Of Vifor Pharma Group , Swiss Federal Council , Vifor Pharma Group , Meeting Of Vifor Pharma Ltd , Fresenius Medical Care , Annual General Meeting , Vifor Pharma Ltd , Annual Report , Annual Financial Statements , Financial Statements , Executive Committee ,